Last update 20 Mar 2025

Recombinant Covid-2019 vaccine (Adenovirus type 5 vector)(Hualan Biological Bacterin)

Overview

Basic Info

Drug Type
Recombinant vector vaccine, Prophylactic vaccine
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
COVID-19
Inactive Indication-
Originator Organization
Guangzhou Enbao Biomedical Technology Co., Ltd.Guangzhou Enbao Biomedical Technology Co., Ltd.Hualan Biological Vaccine, Inc.Hualan Biological Vaccine, Inc.
Active Organization
Guangzhou Enbao Biomedical Technology Co., Ltd.Guangzhou Enbao Biomedical Technology Co., Ltd.Hualan Biological Vaccine, Inc.Hualan Biological Vaccine, Inc.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Recombinant Covid-2019 vaccine (Adenovirus type 5 vector)(Hualan Biological Bacterin)
ChiCTR2100044249
/ RecruitingPhase 3IIT
A global multi-center, randomized, double-blind, placebo-controlled, adaptive designed phase III clinical trial to evaluate the efficacy, safety and immunogenicity of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in adults 18 years of age and older Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vec
100 Clinical Results associated with Recombinant Covid-2019 vaccine (Adenovirus type 5 vector)(Hualan Biological Bacterin)
Login to view more data
100 Translational Medicine associated with Recombinant Covid-2019 vaccine (Adenovirus type 5 vector)(Hualan Biological Bacterin)
Login to view more data
100 Patents (Medical) associated with Recombinant Covid-2019 vaccine (Adenovirus type 5 vector)(Hualan Biological Bacterin)
Login to view more data
100 Deals associated with Recombinant Covid-2019 vaccine (Adenovirus type 5 vector)(Hualan Biological Bacterin)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 2
China
Hualan Biological Vaccine, Inc.Hualan Biological Vaccine, Inc.
29 Mar 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free